Tools

LEADER 03179cam a2200673 i 4500

001 on1233296597;

003 OCoLC;

005 20220614140749.0;

006 m o d f ;

007 cr |||||||||||;

008 210129s2021 dcua ob f000 0 eng c;

019 a| 1237322777;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 4 a| RA644.C67b| .U554 2021;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-21-265;

088 a| GAO-21-265;

110 1 a| United States.b| Government Accountability Office,e| author.=| ^A580995;

245 10 a| COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention :b| report to congressional committees.;

264 1 a| [Washington, D.C.] :b| United States Government Accountability Office,c| 2021.;

300 a| 1 online resource (vii, 333 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "January 2021.";

500 a| "GAO-21-265.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

588 a| Description based on online resource, PDF version; title from cover (GAO, viewed Jan. 28, 2021).;

610 10 a| United States.t| Consolidated Appropriations Act, 2021.=| ^A1428074;

610 10 a| United States.t| Coronavirus Aid, Relief, and Economic Security Act.=| ^A1406814;

650 0 a| COVID-19 (Disease)x| Economic aspectsz| United States.=| ^A1407776;

650 0 a| COVID-19 (Disease)x| Diagnosisz| United States.=| ^A1407776;

650 0 a| COVID-19 (Disease)z| United Statesx| Prevention.=| ^A1407776;

650 0 a| COVID-19 (Disease)x| Treatmentz| United States.=| ^A1407776;

650 0 a| Vaccines industryx| Government policyz| United States.=| ^A577688;

650 0 a| Vaccinesx| Developmentz| United States.=| ^A140104;

650 0 a| Public health administrationz| United States.=| ^A1150;

651 0 a| United Statesx| Appropriations and expenditures.=| ^A126810;

650 7 a| COVID-19 (Disease)x| Diagnosis.2| fast0| (OCoLC)fst01984644;

650 7 a| COVID-19 (Disease)x| Economic aspects.2| fast0| (OCoLC)fst02021810;

650 7 a| COVID-19 (Disease)x| Prevention.2| fast0| (OCoLC)fst02021842;

650 7 a| COVID-19 (Disease)x| Treatment.2| fast0| (OCoLC)fst01984645;

650 7 a| Expenditures, Public.2| fast0| (OCoLC)fst00918345;

650 7 a| Public health administration.2| fast0| (OCoLC)fst01082334;

650 7 a| Vaccines industryx| Government policy.2| fast0| (OCoLC)fst01163594;

651 7 a| United States.2| fast0| (OCoLC)fst01204155?| UNAUTHORIZED;

856 40 u| https://purl.fdlp.gov/GPO/gpo1507847| 0;

922 a| STAFFPICK202205;

922 a| BIBCONEWb| 20210129;

922 a| COVID19CORONAVIRUS;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5561368;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5561368-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 2/12/2021x| EDOCUMENTz| JERESOURCE;

COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees.

Author/creator	United States
Format	Electronic
Publication	[Washington, D.C.] : United States Government Accountability Office, 2021.
Description	1 online resource (vii, 333 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo150784
Subjects	United States. Consolidated Appropriations Act, 2021. United States. Coronavirus Aid, Relief, and Economic Security Act. COVID-19 (Disease)--Vaccination. --United States. --Planning. COVID-19 (Disease)--Economic aspects. --United States. COVID-19 (Disease)--Diagnosis. --United States. COVID-19 (Disease)--United States. --Prevention. COVID-19 (Disease)--Treatment. --United States. Vaccines industry--Government policy. --United States. Vaccines--Development. --United States. Public health administration--United States. United States--Appropriations and expenditures.

General note	"January 2021."
General note	"GAO-21-265."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource, PDF version; title from cover (GAO, viewed Jan. 28, 2021).
Technical rpt number	GAO-21-265
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-21-265

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees.

Click here for more information about this title

Availability